BOSTON, June 06, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) ...
Sen. Dwayne T.D. San Nicolas' Bill 282-37, which seeks to remove the Praxis core mathematics requirement from the Guam Educator Certification, drew support during a May 22 hearing. “I do not want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback